Multidisciplinary Insights on Clinical Guidance for the Use of Proliferation Signal Inhibitors in Heart Transplantation

Keyphrases

• Calcineurin Inhibitors 100%
• MTOR Inhibitor 100%
• Everolimus 100%
• Proliferation Signal Inhibitors 100%
• Heart Transplantation 100%
• Renal Function 50%
• Nephrologists 50%
• Patient Selection 50%
• Malignancy 50%
• Intolerant 50%
• Antiproliferative Activity 50%
• Renal Disease 50%
• Indications for Treatment 50%
• Immunosuppressive Agents 50%
• Sirolimus 50%
• Drug Class 50%
• Cardiac Surgeons 50%
• Cardiologists 50%
• Cardiac Allograft Vasculopathy 50%
• Heart Transplant Recipients 50%
• Drug Use Initiation 50%
• Drug Monitoring 50%
• Adverse Event Management 50%

Medicine and Dentistry

• Immunosuppressive Drug 100%
• Everolimus 100%
• Mammalian Target of Rapamycin Inhibitor 100%
• Heart Transplantation 100%
• Calcineurin Inhibitor 100%
• Kidney Function 50%
• Transplantation 50%
• Adverse Event 50%
• Surgeon 50%
• Heart Graft 50%
• Nephrologist 50%
• Patient Selection 50%
• Cancer 50%
• Rapamycin 50%